The purpose of this report is to provide up-to-date information regarding the drug supply in Philadelphia, Pennsylvania.
Reports
Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances
/ /
The International Narcotics Board published their annual report on precursors and chemicals frequently used in the illicit manufacture of...
The NIH-funded 5-year study published recently by AJHP: Detecting Drug Diversion in Health-System Data Using Machine Learning And Advanced...
The Drug Enforcement Administration's Toxicology Testing Program (DEA TOX) is aimed at detecting new psychoactive substances within the US.
This report provides up-to-date information regarding the status of NPS benzodiazepine prevalance and positivity within the Unites States.
This report provides up-to-date information regarding NPS Stimulant & NPS hallucinogen prevalanve and positivity within the United States.
This report provides up-to-date information regarding the status of synthetic cannabinoid prevalence and positivity within the United States.
This report provides up-to-date information regarding the status of NPS opioid prevalence and positivity within the United States.
In this document, the Legislative Analysis and Public Policy Association (LAPPA) examines state-level legislative and administrative responses to the...
The U.S. Commission on Combating Synthetic Opioid Trafficking, established by the 2020 National Defense Authorization Act, has released its...
Trending Reports
-
DEA Toxicology Testing Program – 2022 Q1 Report May 20, 2022
-
Recommended Scope for NPS Testing in the United States: Q1 2022 May 12, 2022
-
NPS Alert: Synthetic Stimulant Market Rapidly Changing as N,N-Dimethylpentylone Replace Eutylone in Drug Supply Typically Sold as “Ecstacy” or “Molly” April 22, 2022
-
Trend Report: NPS Opioids in the US – Q1 2022 April 12, 2022
-
Trend Report: NPS Stimulants & Hallucinogens in the US – Q1 2022 April 12, 2022